Additionally, prior studies across all BC subtypes reported elevated levels of CD117+ and CD11b+ granulocytes at diagnosis, which decreased after tumor removal by surgery and radiotherapy — supporting the link between tumor burden and measurable immune response (58–60). The gene discussed is ITGAM; the disease is neoplasm.